Cargando…
Low risk of hepatotoxicity from rifampicin when used for cholestatic pruritus: a cross‐disease cohort study
BACKGROUND: The use of rifampicin for cholestatic pruritus is accompanied by concerns over safety, but the availability of real‐world prescribing data is relatively limited. AIM: We sought to describe the rate and characteristics of rifampicin‐induced hepatitis in a mixed aetiology cohort of patient...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5900962/ https://www.ncbi.nlm.nih.gov/pubmed/29468705 http://dx.doi.org/10.1111/apt.14579 |